CD8A and cancer: The activation of PRRs by virus RNA or cancer cells (46, 47) results in upregulation of the type I interferon pathway (mainly from the host DCs) which consequently initiates an antigen-specific adaptive immune response via activation of DCs (especially conventional DCs (48)) and CD8 + T cells.